15 February 2021: Kester Capital, the primary buyout specialist, has expanded its investment team by hiring three new Associates: David Fernie, Jack Murphy and Conor O’Gorman. Earlier this year, Ben Woolley was promoted to Vice President. Ben joined Kester in 2018 and has been involved in a number of Kester’s recent investments.
The new hires and promotion follow Kester’s announcement last week that it completed its investment in drug discovery software business Optibrium, its third investment in the Life Sciences sector.
David Fernie was previously at PwC originally working in their assurance practice, following which he moved into the Healthcare M&A team advising on transactions across a range of healthcare subsectors.
Jack Murphy spent over five years at KPMG latterly working in the M&A team focused on the business services and technology sectors.
Conor O’Gorman joins Kester from Investec’s investment banking division, where he provided M&A advisory services to a range of UK mid-market clients, with a particular focus on financial services and education.
Adam Maidment, Managing Partner of Kester Capital, commented “Having closed our latest fund towards the end of last year we are now looking to ramp up activity and are very pleased to have David, Jack and Conor on board. They join Kester at a busy time and strengthening our investment team will enable us to expand our pipeline as we look for new deal opportunities and bolt-on acquisitions for our investee companies.”
Cameron Crockett, Managing Partner of Kester Capital, added: “As well as expanding the team, we are delighted to promote Ben to Vice President, in recognition of the significant and valuable contribution he has made to Kester Capital. Despite Covid, we are seeing significant activity within the lower mid-market and remain focused on making investments in ambitious UK companies and delivering strong returns to our investors.”